Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.7B | 1.7B | 1.7B | 1.8B |
Cost of revenue | 1.2B | 1.2B | 1.1B | 1.2B |
Gross profit | 514M | 482M | 572M | 582M |
Operating expense | ||||
Research & development | 78M | 97M | 86M | 80M |
Selling general and admin | 248M | 257M | 249M | 263M |
Other operating expenses | 41M | 32M | 31M | 29M |
Operating income | 147M | 96M | 206M | 210M |
Non operating interest income | ||||
Income | 5M | 5M | 5M | 7M |
Expense | 28M | 26M | 36M | 41M |
Other income expense | — | — | — | — |
Pretax income | 29M | -83M | 153M | 131M |
Tax provision | 27M | 50M | 153M | 104M |
Net income | 2M | -133M | 0 | 28M |
Basic EPS | 0.0 | -1.3 | 0.0 | 0.3 |
Diluted EPS | 0.0 | -1.3 | 0.0 | 0.3 |
Basic average shares | 103.1M | 103.9M | 104.7M | 105.2M |
Diluted average shares | 103.6M | 104.6M | 105.4M | 106.0M |
EBITDA | 306M | 370M | 375M | 376M |
Net income from continuing op. | 2M | -133M | 0 | 28M |
Minority interests | -5M | 1M | 0 | 2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |